Sorry for the surprise absence of Cost Curve yesterday. Turns out, there really wasn’t much to say, and I didn’t want to clog your inbox. Speaking of absences, Cost Curve
I would love to write pages and pages about the trove of 340B data that Adam Fein dropped over the weekend, but if you really care about the issue, you
The House yesterday passed a mammoth health bill -- including some of the most sweeping PBM regulations ever -- by a huge margin. It includes a ban on spread pricing